×
About 502,548 results

Benefits of Post-Op Penile Traction Therapy Hold Up Over Time
https://www.medpagetoday.com/urology/prostatecancer/95226

Oct 23rd, 2021 - SCOTTSDALE, Ariz. -- A penile traction therapy (PTT) device produced lasting improvements in men after prostatectomy, a researcher reported. The current data builds on an August 2021 study of 6-month data from 55 men (average age 58.6) who were randomly assigned to control (n=25) or treatment with PTT (n=30) after prostatectomy. The interventions began 1 month post-surgery, and those in the PTT...

Continuous-Release Anti-VEGF Device for AMD Wins FDA Approval
https://www.medpagetoday.com/ophthalmology/generalophthalmology/95225

Oct 23rd, 2021 - The FDA has approved a first-of-its kind continuous delivery system for anti-VEGF therapy for neovascular (wet) age-related macular degeneration (AMD). The Susvimo ocular implant continuously releases 100 mg/mL of ranibizumab directly to the retina over 6 months. Initial implantation and refill can be performed during an office visit with an ophthalmologist. In contrast, conventional intravitre...

Exercise may help stall MS disability and progression
https://www.mdedge.com/neurology/article/247787/multiple-sclerosis/exercise-may-help-stall-ms-disability-and-progression
Jim Kling

Oct 22nd, 2021 - Though once regarded with suspicion, exercise as a therapy for multiple sclerosis (MS) has gained traction in recent years, and has the potential to counter the physical effects often seen among patients, as well as reduce risk of progression. Dr.

Explainer-Americans wonder: Which COVID-19 booster is best?
https://www.reuters.com/article/us-health-coronavirus-boosters-explainer/explainer-americans-wonder-which-covid-19-booster-is-best-idUSKBN2HC243

Oct 22nd, 2021 - CHICAGO (Reuters) - Americans this week were handed a big decision when it comes to getting a COVID-19 vaccine booster. The U.S. Centers for Disease Control and Prevention (CDC) on Thursday said individuals who qualify could choose a different vaccine from the one they received for their initial inoculation. For Americans asking how to choose, the following is what some experts advise: The CDC ...

COVID Vaccine Recipients Also Less Likely to Die of Other Causes
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/95220

Oct 22nd, 2021 - People who were vaccinated against COVID-19 were also less likely to die from non-COVID-19-related causes compared with unvaccinated people, researchers found. The adjusted relative risk of non-COVID-19 mortality ranged from 0.31 (95% CI 0.30-0.33) for those who received two doses of Moderna to 0.54 (95% CI 0.49-0.59) for Johnson & Johnson recipients, reported Stanley Xu, PhD, of Kaiser Permane...

Walmart, Walgreens U.S. stores roll out Moderna, J&J COVID-19 booster shots
https://www.reuters.com/article/health-coronavirus-boosters/update-4-walmart-walgreens-u-s-stores-roll-out-moderna-jj-covid-19-booster-shots-idUSL4N2RI3BC

Oct 22nd, 2021 - (Reuters) -Walgreens Boots Alliance Inc and Walmart Inc said on Friday their U.S. pharmacies started administering COVID-19 booster shots from Moderna Inc and Johnson & Johnson, in addition to previously authorized Pfizer-BioNTech booster. The Centers for Disease Control and Prevention (CDC) on Thursday recommended J&J and Moderna’s booster shots and said Americans can choose a different shot f...

Myeloma Drug Pulled From Market Just Months After Approval
https://www.medpagetoday.com/hematologyoncology/myeloma/95223

Oct 22nd, 2021 - Just months after FDA granted accelerated approval of its myeloma drug, Oncopeptides has pulled melphalan flufenamide (melflufen, Pepaxto) from the market. The decision followed an FDA hold on clinical trials of the drug after data from a confirmatory trial showed an increased mortality risk in patients treated with melflufen. The phase III OCEAN study compared melflufen plus dexamethasone and ...

NSCLC Incidence Declining, Except in Stage I Disease
https://www.medpagetoday.com/radiology/diagnosticradiology/95219

Oct 22nd, 2021 - The overall incidence of non-small cell lung cancer (NSCLC) decreased from 2010 to 2017, with the incidence of stage IV disease falling, and stage I disease rising, researchers determined. A cross-sectional epidemiological analysis showed that NSCLC incidence per 100,000 population declined from 46.4 to 40.9 during the study period. While the incidence of stage II, IIIA, and IIIB disease was st...

Arterial Chemo Tops Chemoembolization for Large Liver Tumors
https://www.medpagetoday.com/hematologyoncology/othercancers/95209

Oct 22nd, 2021 - Patients with unresectable large-volume liver cancer lived significantly longer when treated with hepatic-artery infusion chemotherapy (HAIC) than with transarterial chemoembolization (TACE), a randomized trial from China showed. Median overall survival (OS) increased from 16.1 months with TACE to 23.1 months with FOLFOX (leucovorin, fluorouracil, and oxaliplatin)-HAIC. Progression-free surviva...

Walgreens to administer Moderna, J&J COVID-19 booster shots at U.S. stores
https://www.reuters.com/article/health-coronavirus-boosters/walgreens-to-administer-moderna-jj-covid-19-booster-shots-at-u-s-stores-idUSL4N2RI3AO

Oct 22nd, 2021 - Oct 22 (Reuters) - Walgreens Boots Alliance Inc said on Friday customers can start receiving booster COVID-19 shots from Moderna Inc and Johnson & Johnson at its U.S. stores. The move comes after the Centers for Disease Control and Prevention (CDC) on Thursday recommended the additional doses and said Americans can choose a different shot from their original inoculation as a booster.

Pfizer/BioNTech COVID-19 vaccine shows 90.7% efficacy in trial in children
https://www.reuters.com/article/health-coronavirus-pfizer-children/pfizer-biontech-covid-19-vaccine-shows-90-7-efficacy-in-trial-in-children-idUSL4N2RI2X5

Oct 22nd, 2021 - NEW YORK, Oct 21 (Reuters) - The Pfizer/BioNTech COVID-19 vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of five to 11 year olds, the U.S. drugmaker said on Friday. Sixteen children in the trial who had received a placebo got COVID-19, compared with 3 who were vaccinated, Pfizer said in briefing documents submitted to the U.S. Food and Drug Administration. Because mor...

HCA Healthcare third quarter profit jumps more than threefold
https://www.reuters.com/article/hca-healthcare-results/hca-healthcare-third-quarter-profit-jumps-more-than-threefold-idUSL4N2RI2TB

Oct 22nd, 2021 - Oct 22 (Reuters) - Hospital operator HCA Healthcare Inc reported a 240% rise in third-quarter profit on Friday, driven primarily by the sale of four hospitals in Georgia. Net income attributable to HCA rose to $2.27 billion, or $7.00 per share, in the quarter ended Sept. 30, from $668 million, or $1.95 per share, a year earlier.

Brain Fog After COVID-19 May Last Longer Than We Think
https://www.medpagetoday.com/neurology/generalneurology/95198

Oct 22nd, 2021 - Relatively young people -- ranging from 38 to 59 years old -- showed cognitive dysfunction or "brain fog" months after being diagnosed with COVID-19, a cross-sectional study found. More than 7 months after acute infection, a substantial proportion of COVID-19 patients exhibited deficits in processing speed, executive functioning, category fluency, memory encoding, and recall, reported Jacquelin...

Analysis-Vaccinated Singapore shows zero-COVID countries cost of reopening
https://www.reuters.com/article/us-health-coronavirus-singapore-analysis/analysis-vaccinated-singapore-shows-zero-covid-countries-cost-of-reopening-idUSKBN2HC0OZ

Oct 22nd, 2021 - SINGAPORE (Reuters) -Few are left to inoculate in wealthy Singapore after a vigorous campaign achieved a level of coverage envied by many nations battling the coronavirus pandemic, but a record surge in deaths and infections gives warning of risks that may still lie ahead. Despite mask mandates, strict social curbs and COVID-19 booster doses available for over a month, infections in the Asian c...

Pfizer 90% Effective in Kids; Mix and Match Confusion; Stranded by a Positive Test
https://www.medpagetoday.com/infectiousdisease/covid19/95197

Oct 22nd, 2021 - Note that some links may require registration or subscription. In briefing documents submitted ahead of an FDA advisory committee meeting, Pfizer said its lower-dose COVID-19 vaccine showed 90.7% efficacy (95% CI 67.7-98.3) against symptomatic infection for kids ages 5 to 11. No end in sight -- at least, not yet -- for emergence of new COVID variants. (AP) India just passed the 1 billion-dose m...

Cabozantinib Shows Activity Against RCC Brain Metastases
https://www.medpagetoday.com/hematologyoncology/renalcellcarcinoma/95201

Oct 22nd, 2021 - The tyrosine kinase inhibitor (TKI) cabozantinib (Cabometyx) showed promising activity against brain metastases from renal cell carcinoma (RCC), researchers reported. In a retrospective cohort study of 88 patients with RCC brain metastases, the intracranial response rate with cabozantinib was 55% (95% CI 36-73%) in those with progressing brain metastases without concomitant brain-directed local...

BRIEF-U.S. CDC Advisers Vote In Favor of Moderna, J&J Covid-19 Vaccine Boosters
https://www.reuters.com/article/brief-us-cdc-advisers-vote-in-favor-of-m/brief-u-s-cdc-advisers-vote-in-favor-of-moderna-jj-covid-19-vaccine-boosters-idUSFWN2RH1T6

Oct 21st, 2021 - Oct 21 (Reuters) - * U.S. CDC ADVISERS VOTE TO RECOMMEND MODERNA COVID-19 VACCINE BOOSTER FOR OLDER ADULTS, SOME HIGH-RISK INDIVIDUALS * U.S. CDC ADVISERS VOTE TO RECOMMEND BOOSTER SHOT FOR THOSE WHO RECEIVED JOHNSON & JOHNSON COVID-19 VACCINE Further company coverage:

U.S. CDC advisers recommend Moderna COVID-19 vaccine boosters for some Americans
https://www.reuters.com/article/us-health-coronavirus-moderna-boosters/u-s-cdc-advisers-recommend-moderna-covid-19-vaccine-boosters-for-some-americans-idUSKBN2HB2O8

Oct 21st, 2021 - (Reuters) - A panel of outside advisers to the U.S. Centers for Disease Control and Prevention on Thursday voted to recommend a booster dose of Moderna Inc’s COVID-19 vaccine for people age 65 and older, and some high-risk individuals.

Chipotle beats quarterly same-store sales estimates
https://www.reuters.com/article/chipotle-results/chipotle-beats-quarterly-same-store-sales-estimates-idUSL4N2RH46C

Oct 21st, 2021 - Oct 21 (Reuters) - Chipotle Mexican Grill Inc beat estimates for quarterly same-store sales on Thursday as COVID-19 vaccinations and new items encouraged more people to dine out at its restaurants despite higher prices. Comparable sales rose 15.1% in the third quarter, compared with market expectations of 13.4% growth, according to Refinitiv data. (Reporting by Hilary Russ in New York and Prave...

Ten Ways Healthcare Systems Can Operate Effectively during the COVID-19 Pandemic
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/406832

How can healthcare personnel best protect themselves, patients, and their communities? Find out here.